Ligachem Bioscience Co., Ltd. Asset Profile

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

Year established

2006

Location

Daejeon South Korea

Primary Industry

Pharmaceuticals

About

Founded in 2006 and based in Daejeon, South Korea, Ligachem Bioscience Co., Ltd. is a research-oriented pharmaceutical company. The company was founded by its CEO, Kim Yong-ju. In January 2024, Lego Chem Biosciences raised KRW 550 billion in venture funding from Pan Orion. Following the transaction, Pan Orion will own a 4.93% minority stake in the company. The transaction includes 1.2 million shares previously owned by Lego Chem Biosciences' management. Ligachem's core technology, LigaChemistry, is a drug discovery platform used to develop new drug candidates in areas such as antibiotics, anti-fibrotics, immuno-oncology, and anticoagulants. The company also specializes in providing antibody-drug conjugates (ADCs) through its ConjuALL platform.

Current Investors

Atinum Investment, KB Investment, Yuanta Investment

Request a demo to show more

Primary Industry

Pharmaceuticals

Sub Industries

Pharmaceutical Research & Development

Website

www.legochembio.com

Company Stage

Mature

Total Amount Raised

Subscriber access only

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.